Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126521261 | 12652126 | 1 | I | 20150916 | 20160810 | 20160815 | 20160815 | EXP | US-GLAXOSMITHKLINE-US2016GSK116623 | GLAXOSMITHKLINE | 80.85 | YR | F | Y | 94.00000 | KG | 20160815 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126521261 | 12652126 | 1 | PS | Valaciclovir hydrochloride | VALACYCLOVIR HYDROCHLORIDE | 1 | U | U | 20487 | ||||||||||
| 126521261 | 12652126 | 2 | SS | BUMEX | BUMETANIDE | 1 | Oral | 2 MG, UNK | U | U | 0 | 2 | MG | QD | |||||
| 126521261 | 12652126 | 3 | SS | ALDACTONE | SPIRONOLACTONE | 1 | U | U | 0 | ||||||||||
| 126521261 | 12652126 | 4 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 5 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 6 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 7 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 8 | C | NITROGYCERIN SUSTAINED RELEASE TABLET | 2 | 0 | |||||||||||||
| 126521261 | 12652126 | 9 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 10 | C | NOVOLOG | INSULIN ASPART | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 11 | C | IMURAN | AZATHIOPRINE | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 12 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 13 | C | ARANESP | DARBEPOETIN ALFA | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 14 | C | LIRAGLUTIDE | LIRAGLUTIDE | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 15 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 16 | C | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 17 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 18 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 19 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 20 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 21 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 22 | C | CALCITROL | CALCITRIOL | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 23 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 24 | C | FAMOTIDINE. | FAMOTIDINE | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 25 | C | AMITIZA | LUBIPROSTONE | 1 | 0 | ||||||||||||
| 126521261 | 12652126 | 26 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126521261 | 12652126 | 2 | Cardiovascular disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126521261 | 12652126 | OT |
| 126521261 | 12652126 | LT |
| 126521261 | 12652126 | HO |
| 126521261 | 12652126 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126521261 | 12652126 | Chronic kidney disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126521261 | 12652126 | 2 | 2010 | 0 |